tirzepatide cognitive function A newly published case series reports that GLP-1 receptor agonists (like semaglutide and tirzepatide) may significantly improve symptoms in patients with mast cell activation syndrome (MCAS), even in those without diabetes or Tirzepatide administration improves cognitive impairment

Kristal, A

Does drinking green tea reduce the risk of cognitive decline and, if so, how much do you have to drink

In the studies examined in this review (excluding case series and case reports), the use of semaglutide and tirzepatide [administered at different doses and for varying durations (from 12 weeks to 50 months)] in T1D patients was associated with average/median reductions in HbA1c values of about 0.200.60% and 0.450.90%, respectively

I think we have to be careful about assuming that this [effect] is [from] the drug, says Dr

The main difference is the concentration and intended use, but the stability recommendations are essentially the same